Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Multiple Sclerosis and Related Disorders|April 17, 2015
Quantification of blood-to-brain transfer rate in multiple sclerosisSaeid Taheri, Gary A Rosenberg, Corey FordExpert Opinion on Drug Metabolism & Toxicology|November 28, 2006
Glatiramer acetate therapy for multiple sclerosis: a reviewJai Perumal, Massimo Filippi, Corey Ford, et al.Annals of Neurology|January 31, 2007
Glatiramer acetate in primary progressive multiple sclerosis: results of a multinational, multicenter, double-blind, placebo-controlled trialJerry S Wolinsky, Ponnada A Narayana, Paul O'Connor, et al.International Journal of MS Care|March 7, 2018
Projecting the Adequacy of the Multiple Sclerosis Neurologist WorkforceMichael T Halpern, Heather Kane, Stephanie Teixeira-Poit, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 24, 2016
The Relationship Between Brain MR Spectroscopy and Disability in Multiple Sclerosis: 20-Year Data from the U.S. Glatiramer Acetate Extension StudyOmar Khan, Navid Seraji-Bozorgzad, Fen Bao, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|November 3, 2018
Intracerebral Hemorrhage in Multiple Sclerosis: A Retrospective Cohort StudyMaryam Zulfiqar, Fares Qeadan, Asad Ikram, et al.JAMA Neurology|August 28, 2020
Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical TrialBruce A C Cree, Myla D Goldman, John R Corboy, et al.International Journal of MS Care|January 24, 2014
Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010Stuart D Cook, Suhayl Dhib-Jalbut, Peter Dowling, et al.Pageof 1